SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

SAN

86.09

-1.81%↓

MRK1

110.85

-0.72%↓

ARGX

798.6

+0.83%↑

PHIA

23.47

-0.64%↓

ONC.US

352.04

-3.31%↓

Home・Aktien・Pharming Group NV

P
Pharming Group NV

Geschlossen

1.39 0.94

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.366

Max

1.407

Schlüsselkennzahlen
By Trading Economics
Einkommen	2.9M 7.5M
Verkäufe	4.1M 97M
EPS	0.009
Gewinnspanne	7.758
Angestellte	404

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-43M 954M
Vorheriger Eröffnungskurs	0.45
Vorheriger Schlusskurs	1.39

Pharming Group NV Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Nov. 2025, 19:25 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- 2nd Update

18. Nov. 2025, 18:09 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough -- Update

18. Nov. 2025, 17:39 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Says Anglo American's Pledges to Secure Teck Resources Deal Not Enough

18. Nov. 2025, 16:25 UTC

Wichtige Markttreiber

Diginex Rises on Deal With Digital Asset Platform Evident

18. Nov. 2025, 23:56 UTC

Market Talk

Gold Edges Higher on Likely Technical Recovery -- Market Talk

18. Nov. 2025, 23:39 UTC

Market Talk

Nikkei May Rise on Bargain-Hunting Interest -- Market Talk

18. Nov. 2025, 22:59 UTC

Market Talk

FireFly Metals Can Build Bigger Operation at Green Bay -- Market Talk

18. Nov. 2025, 22:08 UTC

Market Talk

Sandfire's Kalkaroo Project Push Adds to Copper M&A Surge -- Market Talk

18. Nov. 2025, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Defeats FTC's Antitrust Case Alleging Social-Media Monopoly -- 3rd Update

18. Nov. 2025, 22:03 UTC

Ergebnisse

These Stocks Moved the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. Nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

18. Nov. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. Nov. 2025, 21:15 UTC

Market Talk

Private High-Grade Credit Market Is Changing, BlackRock Says -- Market Talk

18. Nov. 2025, 20:46 UTC

Market Talk

U.S. Natural Gas Futures Edge Up on Weather Outlook -- Market Talk

18. Nov. 2025, 20:13 UTC

Market Talk

Distillate Supply Concerns Pull Crude Futures Higher -- Market Talk

18. Nov. 2025, 19:48 UTC

Market Talk

Gold and Silver Turn Lower on Fed Outlook -- Market Talk

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

Anheuser-Busch InBev Nears $700 Million Deal for Party Punch Maker BeatBox -- WSJ

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

Anheuser-Busch InBev in Talks to Buy Party Punch Maker BeatBox, Sources Say -- WSJ

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

AB InBev-BeatBox Deal Could Come Together Soon, Sources Say -- WSJ

18. Nov. 2025, 19:19 UTC

Akquisitionen, Fusionen, Übernahmen

AB InBev Deal Would Value BeatBox At Around $700M, Sources Say -- WSJ

18. Nov. 2025, 18:29 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Nvidia, Microsoft, Home Depot, Cloudflare, Energizer, Honeywell, Medtronic, Klarna, and More -- Barrons.com

18. Nov. 2025, 18:18 UTC

Market Talk

Ethanol Demand Expected to Boost Corn Futures -- Market Talk

18. Nov. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18. Nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

18. Nov. 2025, 17:19 UTC

Market Talk

Ergebnisse

Good Weather Was Bad News for Home Depot's 3Q -- Market Talk

18. Nov. 2025, 17:06 UTC

Ergebnisse

Medtronic Stock Rises After Earnings. What Caught Investors' Attention. -- Barrons.com

18. Nov. 2025, 16:06 UTC

Akquisitionen, Fusionen, Übernahmen

Intuit Stock Gains on OpenAI Deal. ChatGPT Is Coming to TurboTax. -- Barrons.com

18. Nov. 2025, 15:59 UTC

Ergebnisse

Home Depot Cuts Outlook as Home Improvement Slowdown Continues -- Update

18. Nov. 2025, 15:35 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Acquisition Adds to Plenitude's Installed-Capacity Targets, Bolsters France Presence

18. Nov. 2025, 15:35 UTC

Akquisitionen, Fusionen, Übernahmen

Eni: Portfolio Comprises Capacity of Around 760MW in Operation

Peer-Vergleich

Kursveränderung

Pharming Group NV Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pharming Group NV – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pharming Group NV

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.